RTTA 40mg
Research-grade peptide — Purity >99%

RTTA 40mg
A triple agonist peptide targeting the GLP-1, GIP and glucagon receptors, investigated in metabolic research. >99% purity. Supplied strictly for laboratory research use only — not for human or veterinary use.
>99%
C221H342N46O68
40mg
Lyophilised powder
Product Description
RTTA 40mg is supplied as a research-grade lyophilised peptide with the molecular formula C221H342N46O68, at >99% purity, containing 40mg of peptide per vial. Every batch is HPLC- and MS-verified and intended strictly for in-vitro laboratory research.
RTTA 40mg supplied as lyophilised powder for laboratory research use only. Manufactured under cGMP conditions and verified by HPLC and MS analysis. Store refrigerated for up to 12 months.
IMPORTANT: This product is for research purposes only. Not intended for human or veterinary use, consumption or administration.





